A dynamic and agile leader, Bob Carr brings his background as a U.S. Air Force preventive medicine specialist, F-15 flight surgeon and global business leader to his position as a Human Performance Institute Performance Coach and member of the Thought Leadership Council. Since joining the HPI team, Bob has applied his decades of experience to delivering health and wellness solutions to corporate teams and individuals looking to unlock their performance potential.
A top-level executive at a worldwide healthcare corporation for over 25 years, Bob is an innovative strategist and creative problem solver. Adept at leading teams on a global scale with budgets that total in the millions, Bob has a proven record of success in developing and executing strategies that improve the health and wellness of employees unleashing their full potential to drive positive and sustainable business performance.
Through his many academic appointments and membership on industry, community and medical boards where he provides governance and thought leadership, Bob brings unique and current insights into the practices, trends and changes underway in health and performance across the world.
Bob’s medical background, global experience, multiple language fluency and well-rounded education, including a degree in French Literature and Language, add to his ability to navigate cultures worldwide. An avid traveler, reader and hiker, Bob’s expertise is truly multi-dimensional and an ideal fit for his position as a Performance Coach.
The Johnson & Johnson Human Performance Institute is the pioneer in delivering a science-based energy management training solution. Based on over 30 years of proprietary research, the Human Performance Institute has worked with elite performers, including Olympic gold medalists, military Special Forces, Hostage Rescue teams, surgeons, and Fortune 500 CEOs to achieve sustained high performance. In 2014 alone, 25 of the Fortune 100 companies participated in Corporate Athlete® training, delivered across 32 countries, in over 500 sessions.
*Bob Carr recently retired from GlaxoSmithKline in July of 2014